
    
      Ten patients will be assessed during a closed-loop night and an open-loop night in random
      order.

      The primary objective is to assess the ability of SP-MPC controler to maintain euglycemia and
      avoid hypoglycaemia during the night, compared to open loop in type 1 diabetic patients
      treated by insulin pump.
    
  